Richard R. Furman, M.D.

Medical Oncology

Richard R. Furman, M.D.

Dr. Furman is Director of the CLL Research Center at Weill Cornell Medical College and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology.  His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.

Back to topBack To Top